Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial
Published Online: 2019-03-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Amily Zhang•Axel Heidenreich•Bertrand Tombal•Celestia Higano•Chris Parker•Eli Rosenbaum•Franco Nolè•Fred Saad•Go Kimura•Heiko Krissel•Josep Maria Piulats•Junwu Shen•Kurt Miller•Luis Eduardo Zucca•Martin Boegemann•Matthew Smith•Michael Teufel•Nobuaki Matsubara•Oleg Karyakin•Quan Sing Ng•Volker Wagner•Vsevolod Matveev•William Carlos Nahas•Yoshiyuki Kakehi
